Clinical Trial Update: Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease [NA]

View source ↗

Summary

A clinical trial evaluating continuous intraventricular methotrexate for leptomeningeal metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastases

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leptomeningeal Metastases | NA | Status: WITHDRAWN